MacroGenics Total Assets from 2010 to 2024
MGNX Stock | USD 15.70 0.53 3.27% |
Total Assets | First Reported 2011-12-31 | Previous Quarter 340 M | Current Value 298.4 M | Quarterly Volatility 102.6 M |
Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.1 M, Interest Expense of 1.5 M or Selling General Administrative of 37 M, as well as many exotic indicators such as Price To Sales Ratio of 10.6 K, Dividend Yield of 0.0 or PTB Ratio of 4.1 K. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
MacroGenics | Total Assets |
Latest MacroGenics' Total Assets Growth Pattern
Below is the plot of the Total Assets of MacroGenics over the last few years. Total assets refers to the total amount of MacroGenics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in MacroGenics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. MacroGenics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MacroGenics' overall financial position and show how it may be relating to other accounts over time.
View | Last Reported 298.42 M | 10 Years Trend |
|
Total Assets |
Timeline |
MacroGenics Total Assets Regression Statistics
Arithmetic Mean | 249,881,391 | |
Geometric Mean | 208,514,259 | |
Coefficient Of Variation | 47.85 | |
Mean Deviation | 102,750,734 | |
Median | 298,418,000 | |
Standard Deviation | 119,561,486 | |
Sample Variance | 14294.9T | |
Range | 325M | |
R-Value | 0.73 | |
Mean Square Error | 7079T | |
R-Squared | 0.54 | |
Significance | 0 | |
Slope | 19,648,890 | |
Total Sum of Squares | 200129.3T |
MacroGenics Total Assets History
Other Fundumenentals of MacroGenics
MacroGenics Total Assets component correlations
Click cells to compare fundamentals
About MacroGenics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include MacroGenics income statement, its balance sheet, and the statement of cash flows. MacroGenics investors use historical funamental indicators, such as MacroGenics's Total Assets, to determine how well the company is positioned to perform in the future. Although MacroGenics investors may use each financial statement separately, they are all related. The changes in MacroGenics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MacroGenics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on MacroGenics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Total Assets | 298.4 M | 287.5 M | |
Intangibles To Total Assets | 0.00 | 0.00 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MacroGenics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MacroGenics' short interest history, or implied volatility extrapolated from MacroGenics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of MacroGenics Correlation against competitors. For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for MacroGenics Stock analysis
When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Transaction History View history of all your transactions and understand their impact on performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is MacroGenics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MacroGenics. If investors know MacroGenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MacroGenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 0.949 | Quarterly Revenue Growth (0.85) | Return On Assets (0.36) | Return On Equity (0.06) |
The market value of MacroGenics is measured differently than its book value, which is the value of MacroGenics that is recorded on the company's balance sheet. Investors also form their own opinion of MacroGenics' value that differs from its market value or its book value, called intrinsic value, which is MacroGenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MacroGenics' market value can be influenced by many factors that don't directly affect MacroGenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MacroGenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if MacroGenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MacroGenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.